USDM’s AI Center of Excellence delivers the governance, strategy, validation, and managed services infrastructure that life sciences organizations need to adopt AI compliantly — from first pilot to enterprise scale. We are the only partner that governs AI AND builds it within GxP guardrails.
USDM’s AI practice is built on demonstrated delivery across pharma, biotech, and medical device clients of every size and stage. Every engagement adds to a growing body of repeatable, validated methodology.
Global Biopharma
Responsible AI Assurance Framework + 150-vendor TPRM managed service — USDM’s flagship AI governance replication model. OSINT-powered intelligence dashboards across the full vendor portfolio.
MedTech Manufacturer
AI assessment readout, 8-week POC proposal for EnableIQ™ GxP Document ChatBot, and training curriculum for AI citizen development governance.
Clinical-stage biotech
AI use case scoring methodology, executive briefing deck, and AI governance framework for a newly-formed biopharma with high-growth AI ambitions.
Therapeutic Biopharma
Full 18-slide interactive AI briefing build — deployed as a client-facing sales enablement tool replacing traditional PowerPoint presentation decks.
Commercial-Stage Biopharma
GxP AI capabilities briefing across pharmacovigilance, medical affairs, and clinical operations — framed for IT and Quality leadership alignment.
Multiple Device Clients
EU AI Act compliance preparation programs — classification, Annex IV documentation, and unified FDA + EU AI Act + ISO 42001 compliance frameworks.
AI CoE Platform
USDM’s AI System Lifecycle Framework, TRUST-AI governance architecture, AIGaaS service blueprint, XAI SOP, and Model Governance Framework — proprietary IP deployed across all engagements.
900+ Life Sciences Clients
Cloud Assurance managed subscription delivering continuous GxP compliance across Google, Microsoft, Veeva, ServiceNow, Salesforce, Box, and Oracle platforms.